These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17459933)

  • 21. Serological responses in calves to vaccines against bovine respiratory syncytial, infectious bovine rhinotracheitis, bovine viral diarrhoea and parainfluenza-3 viruses.
    Tollis M; Di Trani L; Cordioli P; Vignolo E; Di Pasquale I
    Dev Biol Stand; 1996; 86():147-56. PubMed ID: 8785944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.
    Ellis JA; West KH; Waldner C; Rhodes C
    Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
    Ellis JA; Gow SP; Goji N
    J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
    Kalina WV; Woolums AR; Gershwin LJ
    Vaccine; 2005 Aug; 23(37):4625-30. PubMed ID: 15967545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.
    Schmidt U; Beyer J; Polster U; Gershwin LJ; Buchholz UJ
    J Virol; 2002 Dec; 76(23):12355-9. PubMed ID: 12414977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunology of bovine respiratory syncytial virus infection of cattle.
    Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2012 May; 35(3):253-7. PubMed ID: 22410266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    Kim S; Jang JE; Yu JR; Chang J
    Vaccine; 2010 May; 28(22):3801-8. PubMed ID: 20362203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
    Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
    J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
    Oumouna M; Mapletoft JW; Karvonen BC; Babiuk LA; van Drunen Littel-van den Hurk S
    J Virol; 2005 Feb; 79(4):2024-32. PubMed ID: 15681404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.
    Garlapati S; Garg R; Brownlie R; Latimer L; Simko E; Hancock RE; Babiuk LA; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2012 Jul; 30(35):5206-14. PubMed ID: 22713718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
    Johnson JE; McNeil LK; Megati S; Witko SE; Roopchand VS; Obregon JH; Illenberger DM; Kotash CS; Nowak RM; Braunstein E; Yurgelonis I; Jansen KU; Kalyan NK; Sidhu MK
    Immunol Lett; 2013 Feb; 150(1-2):134-44. PubMed ID: 23261719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.
    Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
    Vaccine; 1997 Dec; 15(17-18):1908-16. PubMed ID: 9413101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
    Garg R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2015 Mar; 33(11):1338-44. PubMed ID: 25637860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.
    Ellis J; Gow S; Bolton M; Burdett W; Nordstrom S
    Can Vet J; 2014 Dec; 55(12):1180-5. PubMed ID: 25477547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local and systemic immune responses in mice to intranasal delivery of peptides representing bovine respiratory syncytial virus epitopes encapsulated in poly (DL-lactide-co-glycolide) microparticles.
    Kavanagh OV; Adair BM; Welsh MD; Earley B
    Res Vet Sci; 2013 Jun; 94(3):809-12. PubMed ID: 23312498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.